QQQ   355.04 (+0.23%)
AAPL   170.43 (-0.89%)
MSFT   312.79 (+0.21%)
META   297.74 (-0.41%)
GOOGL   130.54 (+1.54%)
AMZN   125.98 (+0.00%)
TSLA   240.50 (-1.48%)
NVDA   424.68 (+1.33%)
NIO   8.46 (+0.59%)
BABA   86.19 (+0.33%)
AMD   98.07 (+2.20%)
T   14.87 (-1.00%)
F   12.39 (-0.32%)
MU   68.21 (+0.40%)
CGC   0.89 (-3.49%)
GE   110.89 (+0.87%)
DIS   79.90 (-0.19%)
AMC   7.57 (-4.30%)
PFE   32.10 (-0.93%)
PYPL   57.34 (-2.70%)
NFLX   377.59 (-0.44%)
QQQ   355.04 (+0.23%)
AAPL   170.43 (-0.89%)
MSFT   312.79 (+0.21%)
META   297.74 (-0.41%)
GOOGL   130.54 (+1.54%)
AMZN   125.98 (+0.00%)
TSLA   240.50 (-1.48%)
NVDA   424.68 (+1.33%)
NIO   8.46 (+0.59%)
BABA   86.19 (+0.33%)
AMD   98.07 (+2.20%)
T   14.87 (-1.00%)
F   12.39 (-0.32%)
MU   68.21 (+0.40%)
CGC   0.89 (-3.49%)
GE   110.89 (+0.87%)
DIS   79.90 (-0.19%)
AMC   7.57 (-4.30%)
PFE   32.10 (-0.93%)
PYPL   57.34 (-2.70%)
NFLX   377.59 (-0.44%)
QQQ   355.04 (+0.23%)
AAPL   170.43 (-0.89%)
MSFT   312.79 (+0.21%)
META   297.74 (-0.41%)
GOOGL   130.54 (+1.54%)
AMZN   125.98 (+0.00%)
TSLA   240.50 (-1.48%)
NVDA   424.68 (+1.33%)
NIO   8.46 (+0.59%)
BABA   86.19 (+0.33%)
AMD   98.07 (+2.20%)
T   14.87 (-1.00%)
F   12.39 (-0.32%)
MU   68.21 (+0.40%)
CGC   0.89 (-3.49%)
GE   110.89 (+0.87%)
DIS   79.90 (-0.19%)
AMC   7.57 (-4.30%)
PFE   32.10 (-0.93%)
PYPL   57.34 (-2.70%)
NFLX   377.59 (-0.44%)
QQQ   355.04 (+0.23%)
AAPL   170.43 (-0.89%)
MSFT   312.79 (+0.21%)
META   297.74 (-0.41%)
GOOGL   130.54 (+1.54%)
AMZN   125.98 (+0.00%)
TSLA   240.50 (-1.48%)
NVDA   424.68 (+1.33%)
NIO   8.46 (+0.59%)
BABA   86.19 (+0.33%)
AMD   98.07 (+2.20%)
T   14.87 (-1.00%)
F   12.39 (-0.32%)
MU   68.21 (+0.40%)
CGC   0.89 (-3.49%)
GE   110.89 (+0.87%)
DIS   79.90 (-0.19%)
AMC   7.57 (-4.30%)
PFE   32.10 (-0.93%)
PYPL   57.34 (-2.70%)
NFLX   377.59 (-0.44%)
NASDAQ:SNDX

Syndax Pharmaceuticals (SNDX) News Today

$15.13
-0.63 (-4.00%)
(As of 04:26 PM ET)
Compare
Today's Range
$14.99
▼
$15.93
50-Day Range
$15.71
▼
$21.77
52-Week Range
$14.99
▼
$29.86
Volume
1.08 million shs
Average Volume
838,721 shs
Market Capitalization
$1.05 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$36.00
ProfileAnalyst RatingsChartCompetitorsEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesOptions ChainSEC FilingsShort InterestSocial MediaSustainability
SourceHeadline
finance.yahoo.com logoWe Think Syndax Pharmaceuticals (NASDAQ:SNDX) Can Afford To Drive Business Growth
finance.yahoo.com - September 27 at 8:33 AM
MarketBeat logoSyndax Pharmaceuticals Sees Unusually High Options Volume (NASDAQ:SNDX)
americanbankingnews.com - September 23 at 1:24 AM
marketbeat.com logoSyndax Pharmaceuticals Target of Unusually High Options Trading (NASDAQ:SNDX)
marketbeat.com - September 22 at 2:34 PM
benzinga.com logoLooking At Syndax Pharmaceuticals's Recent Unusual Options Activity
benzinga.com - September 20 at 5:00 PM
marketbeat.com logoPrelude Capital Management LLC Invests $231,000 in Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX)
marketbeat.com - September 20 at 4:11 AM
marketbeat.com logoBVF Inc. IL Raises Holdings in Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX)
marketbeat.com - September 12 at 4:47 AM
seekingalpha.com logoSyndax Pharmaceuticals: Positive Axatilimab Phase 2 Results
seekingalpha.com - September 8 at 10:42 AM
marketbeat.com logoSwiss National Bank Decreases Position in Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX)
marketbeat.com - September 6 at 4:14 AM
marketbeat.com logoSyndax Pharmaceuticals, Inc. (NASDAQ:SNDX) Stock Position Decreased by Wellington Management Group LLP
marketbeat.com - September 4 at 7:49 AM
marketbeat.com logoProfund Advisors LLC Buys Shares of 52,605 Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX)
marketbeat.com - September 1 at 7:53 AM
finance.yahoo.com logoSyndax Announces Participation at the Citi 18th Annual BioPharma Conference
finance.yahoo.com - August 31 at 8:20 PM
msn.com logoJP Morgan Maintains Syndax Pharmaceuticals (SNDX) Overweight Recommendation
msn.com - August 16 at 4:47 PM
marketbeat.com logoSyndax Pharmaceuticals, Inc. (NASDAQ:SNDX) Receives Average Rating of "Buy" from Analysts
marketbeat.com - August 16 at 2:20 AM
marketbeat.com logoVictory Capital Management Inc. Has $339,000 Stake in Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX)
marketbeat.com - August 14 at 4:42 AM
marketbeat.com logoInsider Selling: Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX) Director Sells 52,855 Shares of Stock
marketbeat.com - August 10 at 8:17 AM
markets.businessinsider.com logoSyndax Pharmaceuticals (SNDX) Gets a Buy from Robert W. Baird
markets.businessinsider.com - August 8 at 7:49 AM
marketbeat.com logoSyndax Pharmaceuticals (NASDAQ:SNDX) Posts Earnings Results
marketbeat.com - August 4 at 4:37 PM
markets.businessinsider.com logoH.C. Wainwright Keeps Their Buy Rating on Syndax Pharmaceuticals (SNDX)
markets.businessinsider.com - August 4 at 4:33 PM
marketbeat.com logoSyndax Pharmaceuticals' (SNDX) Buy Rating Reiterated at HC Wainwright
marketbeat.com - August 4 at 1:59 PM
finance.yahoo.com logoSyndax Pharmaceuticals Reports Second Quarter 2023 Financial Results and Provides Clinical and Business Update
finance.yahoo.com - August 3 at 8:27 PM
msn.com logoSyndax Pharmaceuticals (SNDX) Price Target Increased by 8.43% to 37.29
msn.com - August 2 at 2:37 AM
msn.com logoScotiabank Initiates Coverage of Syndax Pharmaceuticals (SNDX) with Sector Outperform Recommendation
msn.com - July 28 at 10:38 AM
markets.businessinsider.com logoWhat 7 Analyst Ratings Have To Say About Syndax Pharmaceuticals
markets.businessinsider.com - July 27 at 12:56 AM
msn.com logoBarclays Maintains Syndax Pharmaceuticals (SNDX) Overweight Recommendation
msn.com - July 27 at 12:56 AM
finance.yahoo.com logoSyndax to Announce Second Quarter 2023 Financial Results and Host Conference Call and Webcast on August 3, 2023
finance.yahoo.com - July 25 at 9:43 AM
msn.com logoHC Wainwright & Co. Reiterates Syndax Pharmaceuticals (SNDX) Buy Recommendation
msn.com - July 24 at 7:21 PM
markets.businessinsider.com logoH.C. Wainwright Remains a Buy on Syndax Pharmaceuticals (SNDX)
markets.businessinsider.com - July 24 at 2:18 PM
finance.yahoo.com logoSyndax and Incyte Announce Positive Topline Results from the Pivotal AGAVE-201 Trial of Axatilimab in Chronic Graft-Versus-Host Disease
finance.yahoo.com - July 24 at 7:44 AM
marketbeat.com logoSG Americas Securities LLC Raises Stake in Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX)
marketbeat.com - July 23 at 5:36 AM
marketbeat.com logo39,932 Shares in Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX) Purchased by Virtu Financial LLC
marketbeat.com - July 21 at 7:37 AM
markets.businessinsider.com logoSyndax Pharmaceuticals Set for Potential Breakthrough with Revumenib: Analyst Calls It 'Potentially Best-In-Class' In Competitive Landscape
markets.businessinsider.com - July 11 at 6:07 PM
msn.com logoGuggenheim Initiates Coverage of Syndax Pharmaceuticals (SNDX) with Buy Recommendation
msn.com - July 11 at 1:06 PM
marketbeat.com logoInspire Investing LLC Raises Holdings in Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX)
marketbeat.com - July 9 at 6:55 AM
marketbeat.com logoInspire Advisors LLC Makes New Investment in Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX)
marketbeat.com - July 7 at 11:46 AM
marketbeat.com logoAssenagon Asset Management S.A. Purchases 329,577 Shares of Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX)
marketbeat.com - July 3 at 5:24 AM
markets.businessinsider.com logoAnalysts Offer Insights on Healthcare Companies: Syndax Pharmaceuticals (SNDX) and Accolade (ACCD)
markets.businessinsider.com - June 30 at 8:17 AM
msn.com logoBTIG Maintains Syndax Pharmaceuticals (SNDX) Buy Recommendation
msn.com - June 27 at 9:27 AM
marketbeat.com logoStonnington Group LLC Acquires New Position in Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX)
marketbeat.com - June 27 at 6:13 AM
marketbeat.com logoSyndax Pharmaceuticals, Inc. (NASDAQ:SNDX) Given Consensus Rating of "Buy" by Analysts
marketbeat.com - June 27 at 2:15 AM
benzinga.com logoBTIG Maintains Buy on Syndax Pharmaceuticals, Raises Price Target to $35
benzinga.com - June 26 at 10:20 AM
markets.businessinsider.com logoBTIG Sticks to Their Buy Rating for Syndax Pharmaceuticals (SNDX)
markets.businessinsider.com - June 26 at 10:20 AM
marketbeat.com logoSyndax Pharmaceuticals, Inc. (NASDAQ:SNDX) Holdings Lessened by HealthCor Management L.P.
marketbeat.com - June 15 at 6:11 AM
marketbeat.com logoEversept Partners LP Acquires 409,279 Shares of Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX)
marketbeat.com - June 14 at 11:23 AM
seekingalpha.com logoSyndax Pharmaceuticals: Precision Oncology Leveraging Strong Financials And R&D
seekingalpha.com - June 8 at 9:12 AM
marketbeat.com logoVictory Capital Management Inc. Reduces Holdings in Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX)
marketbeat.com - June 7 at 5:31 AM
marketbeat.com logoPrincipal Financial Group Inc. Has $695,000 Position in Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX)
marketbeat.com - June 5 at 5:07 AM
marketbeat.com logoDimensional Fund Advisors LP Grows Position in Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX)
marketbeat.com - June 2 at 5:24 AM
marketbeat.com logoSyndax Pharmaceuticals, Inc. (NASDAQ:SNDX) Receives Average Rating of "Moderate Buy" from Brokerages
marketbeat.com - June 2 at 2:45 AM
marketbeat.com logoRaymond James Financial Services Advisors Inc. Makes New $880,000 Investment in Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX)
marketbeat.com - May 30 at 4:47 AM
marketbeat.com logoRussell Investments Group Ltd. Makes New $1.01 Million Investment in Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX)
marketbeat.com - May 26 at 4:41 AM
Get Syndax Pharmaceuticals News Delivered to You Automatically

Sign up to receive the latest news and ratings for SNDX and its competitors with MarketBeat's FREE daily newsletter.



SNDX Media Mentions By Week

SNDX Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

SNDX
News Sentiment
▼
0.72

0.86
▲
Average
Medical
News Sentiment

SNDX News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

SNDX Articles
This Week
▼
6

2
▲
SNDX Articles
Average Week

Get Syndax Pharmaceuticals News Delivered to You Automatically

Sign up to receive the latest news and ratings for SNDX and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools

Related Companies:
Headlines Tools:
This page (NASDAQ:SNDX) was last updated on 9/27/2023 by MarketBeat.com Staff

My Account -